Canary Islands, first European destination in ROBLOX
17.1.2025 13:00:00 CET | news aktuell GmbH | Press release
Turismo de Canarias presents Find the Seasouls, an interactive experience within ROBLOX designed to promote environmental care in new generations, calling for respect for natural parks, protected spaces and the biodiversity of the islands

Canary Islands Tourism is moving into the future with the launch of Find the Seasouls, Europe's first destination experience within ROBLOX, the immersive global social platform that has more than 80 million daily active users around the world and that It is currently one of the main meeting places for the Alpha and Z generations.
Find the seasouls is an interactive experience designed to encourage care for the environment in new generations, calling for respect for natural parks, protected spaces and the biodiversity of the islands. Users travel with their avatar through the 8 Canary Islands, visiting landscapes such as the volcanoes of Lanzarote or the junipers of El Hierro, and they look for very special sea creatures, the Seasouls, characters inspired by animals that inhabit the islands. These creatures and their description have been created in collaboration with the prestigious oceanographer Cristina Fernández Gil, seeking to be faithful to the biodiversity of the Islands.
The traveler of the future learns by playing
The objective of this project is to connect with the tourist of the future (Alpha and Z generations), influencing the education of caring for the environment when visiting destinations .
Since the experience is mainly aimed at the little ones, it has been designed prioritizing values linked to sustainability and taking into account a maximum exposure time to the screen. Roblox automatically translates the video game into fourteen languages, including Spanish, English, German, French, and Portuguese.
Find the Seasouls is a project by the creative agency Flecher.co developed by Brandnewverse, subsidized by the European Regional Development Fund (ERDF).
Images

Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:52:44 CEST | Press release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Democracy News Alliance: Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:55:20 CEST | Press release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found.
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 13:06:01 CEST | Press release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 10:17:49 CEST | Press release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom